YOUR SEARCH FOR Text 211 RESULTS
31 of Total
Form 4 for Cagnoni Pablo J filed 03/19/2026
… … Form 4 for Cagnoni Pablo J filed 03/19/2026 …
32 of Total
Form 4 for Trotta Matteo filed 03/26/2026
… … Form 4 for Trotta Matteo filed 03/26/2026 …
33 of Total
The Science Within the Skin: Demystifying Vitiligo for Patients | Incyte Stories
… Within the Skin : Demystifying Vitiligo for Patients At Incyte, ensuring the patients we …
34 of Total
Microsoft Word - Incyte Compliance Program for CA Final Nov 2011.doc
… … Microsoft Word - Incyte Compliance Program for CA Final Nov 2011.doc …
35 of Total
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativ
… New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at … were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients …
36 of Total
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advance
… news Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line … chemotherapy) will be the first PD-1 immunotherapy treatment for patients with …
37 of Total
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativ
… New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativ …
38 of Total
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advance
… … Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line …
39 of Total
Investors | Incyte
… Quick Links Investor Presentation Responsibility News Portfolio … Meeting All press releases Latest Events Mar 11 2026 Mar 11 2026 Barclays 28th Annual Global …
40 of Total
Stock information | Incyte
… Stock Quote & Chart Historical Lookup Analyst Coverage Firm Analyst Bank …